Terapia Intensiva
Estudo observacional | Envolvimento farmacêutico no cuidado de pacientes críticos pode reduzir a utilização de recursos, os eventos adversos medicamentosos e os custos médicos.
4 Fev, 2022 | 15:11h
Comentário do autor no Twitter (fio – clique para saber mais)
PHARM-CRIT Study
👩🔬 215 ICU PharmDs at 85 centers
💊55,926 accepted interventions on 27,681 patients over 3,148 shifts
💵$23,404,089 cost avoidance; monetary benefit-to-cost ratio for ICU pharmacists $3.3:1 – $9.6:1@SCCM_CPP @SCCM #TwitteRx #PharmICU https://t.co/Hv4jPwU6eb— Megan Rech, PharmD, MS (@MeganARech) December 16, 2021
Consenso | Nefrotoxinas e lesão renal aguda.
4 Fev, 2022 | 15:01hM-A | Vasopressina e glicocorticoides na parada cardíaca em pacientes internados.
4 Fev, 2022 | 14:56hConteúdo relacionado: RCT: Vasopressin + Methylprednisolone increase the likelihood of return of spontaneous circulation compared to placebo in patients with in-hospital cardiac arrest.
Comentário no Twitter
Systemic review and meta analysis post VAM-IHCA.
▶️ Moderate certainty for benefit with steroids and vasopressin on ROSC
▶️ Less certainty for longer term outcomes @mathiasholmb@LarsWAndersen1 @AsgerGranfeldthttps://t.co/K3jZ1gBs1h— Critical Care Reviews (@CritCareReviews) January 4, 2022
Revisão | Tratamento multidisciplinar da lesão traqueobrônquica.
4 Fev, 2022 | 14:27hMultidisciplinary management of tracheobronchial injury – European Respiratory Review
FDA interrompe o uso de anticorpos monoclonais que não funcionam contra a Ômicron.
31 Jan, 2022 | 08:56hFDA halts use of antibody drugs that don’t work vs. omicron – Associated Press
Conteúdo relacionado: Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
Diretrizes ELSO para circuitos de oxigenação extracorpórea para pacientes adultos e pediátricos.
31 Jan, 2022 | 08:47hELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits – ASAIO Journal
Conteúdo relacionado: ELSO Guidelines for anticoagulation in adult and pediatric patients using extracorporeal membrane oxygenation (ECMO).
Comentário no Twitter
The new ELSO guidelines, describing #ECMO circuits for all
patient populations, adult and pediatric, are now available, open access on @asaiojournal These consensus guidelines describe safe practice based on extensive experience.
Download full text #FOAMcchttps://t.co/Miu9sbY2gs pic.twitter.com/HU6zCwX031— ELSO (@ELSOOrg) January 28, 2022
Resumo de diretriz | Tratamento dos 10 eventos adversos imunológicos mais comuns em pacientes em imunoterapia.
31 Jan, 2022 | 08:39hArtigo original: ASCO Guideline Update: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
Conteúdos relacionados:
Clinical practice guideline on immune checkpoint inhibitor-related adverse events.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (várias fontes sobre o tema)
Estudo randomizado | Imunoglobulina hiperimune não melhorou os desfechos de pacientes internados com COVID-19.
28 Jan, 2022 | 17:24hComentários:
Diretrizes ELSO para anticoagulação em pacientes adultos e pediátricos usando oxigenação extracorpórea (extracorporeal membrane oxygenation – ECMO).
28 Jan, 2022 | 16:59h2021 ELSO Adult and Pediatric Anticoagulation Guidelines – ASAIO Journal
Comentário no Twitter
The updated @ELSOOrg adult & pediatric anticoagulation guidelines just out, open access, on @asaiojournal
🩸anticoagulants
🩸therapeutic monitoring of anticoagulants
🩸management of bleeding & thrombotic complications#FOAMcc #FOAMecmo #PedsICU
🖇 https://t.co/sC8iQK6YL0 pic.twitter.com/hkbVoNBDkR— ELSO (@ELSOOrg) January 21, 2022